Inovio Pharmaceuticals Correlations

INO Stock

USD 4.19 0.18 4.49%

The current 90-days correlation between Inovio Pharmaceuticals and Vaxart Inc is 0.25 (i.e., Modest diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Inovio Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Inovio Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Inovio Pharmaceuticals Correlation With Market

Very weak diversification

The correlation between Inovio Pharmaceuticals and DJI is 0.44 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Inovio Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Inovio Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

To learn how to invest in Inovio Stock, please use our How to Invest in Inovio Pharmaceuticals guide.

Moving together with Inovio Stock

0.65	HLN	Haleon plc	Pair Corr
0.83	JNJ	Johnson Johnson Fiscal Year End 28th of January 2025	Pair Corr
0.84	LLY	Eli Lilly Sell-off Trend	Pair Corr
0.84	MRK	Merck Company Fiscal Year End 6th of February 2025	Pair Corr
0.78	PFE	Pfizer Inc Aggressive Push	Pair Corr
0.87	RDY	Dr Reddys Laboratories	Pair Corr
0.86	TAK	Takeda Pharmaceutical	Pair Corr
0.62	INMB	INmune Bio	Pair Corr
0.77	LTRN	Lantern Pharma	Pair Corr
0.66	REVB	Revelation Biosciences	Pair Corr
0.65	ABBV	AbbVie Inc	Pair Corr
0.89	AMGN	Amgen Inc	Pair Corr
0.65	ANEB	Anebulo Pharmaceuticals	Pair Corr
0.67	ANRO	Alto Neuroscience,	Pair Corr
0.78	SIGA	SIGA Technologies	Pair Corr
0.72	TEVA	Teva Pharma Industries Sell-off Trend	Pair Corr

Moving against Inovio Stock

0.88	BMY	Bristol Myers Squibb Aggressive Push	Pair Corr
0.77	ESPR	Esperion Therapeutics	Pair Corr
0.7	GILD	Gilead Sciences	Pair Corr
0.67	EWTX	Edgewise Therapeutics	Pair Corr
0.63	VTRS	Viatris	Pair Corr
0.61	BHC	Bausch Health Companies	Pair Corr
0.56	WAT	Waters	Pair Corr
0.45	BFRIW	Biofrontera Warrants	Pair Corr
0.42	EBS	Emergent Biosolutions	Pair Corr
0.36	GANX	Gain Therapeutics	Pair Corr
0.31	BCTXW	BriaCell Therapeutics	Pair Corr
0.86	BSX	Boston Scientific Corp	Pair Corr
0.58	DXCM	DexCom Inc	Pair Corr
0.54	MNMD	Mind Medicine	Pair Corr
0.44	ABT	Abbott Laboratories Fiscal Year End 22nd of January 2025	Pair Corr
0.42	CPRX	Catalyst Pharmaceuticals	Pair Corr

Related Correlations Analysis

	NVAX	VXRT	ENVB	CWBR	OCEA	HEPA	ELEV	AVRO
NVAX		0.8	0.37	-0.47	0.69	0.06	-0.06	-0.88	NVAX
VXRT	0.8		0.75	-0.59	0.85	0.36	0.2	-0.73	VXRT
ENVB	0.37	0.75		-0.48	0.75	0.37	0.35	-0.36	ENVB
CWBR	-0.47	-0.59	-0.48		-0.46	-0.43	-0.37	0.36	CWBR
OCEA	0.69	0.85	0.75	-0.46		0.36	0.18	-0.73	OCEA
HEPA	0.06	0.36	0.37	-0.43	0.36		0.68	-0.13	HEPA
ELEV	-0.06	0.2	0.35	-0.37	0.18	0.68		0.05	ELEV
AVRO	-0.88	-0.73	-0.36	0.36	-0.73	-0.13	0.05		AVRO
	NVAX	VXRT	ENVB	CWBR	OCEA	HEPA	ELEV	AVRO

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

OCEA	+ 0.85	VXRT
VXRT	+ 0.8	NVAX
ENVB	+ 0.75	VXRT
OCEA	+ 0.75	ENVB
OCEA	+ 0.69	NVAX
ELEV	+ 0.68	HEPA

High negative correlations

AVRO	- 0.88	NVAX
AVRO	- 0.73	OCEA
AVRO	- 0.73	VXRT
CWBR	- 0.59	VXRT
CWBR	- 0.48	ENVB
CWBR	- 0.47	NVAX

Risk-Adjusted Indicators

There is a big difference between Inovio Stock performing well and Inovio Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Inovio Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
NVAX	3.77	(0.34)	0.00	(0.30)	0.00	0.00	9.89	(7.08)	38.60
VXRT	2.73	(0.60)	0.00	(0.72)	0.00	0.00	4.88	(5.95)	20.06
ENVB	3.25	(0.61)	0.00	(3.83)	0.00	0.00	6.25	(7.50)	28.33
CWBR	7.34	2.79	0.33	(0.85)	5.34	(11.19)	5.73	(5.59)	250.97
OCEA	3.51	(0.36)	0.00	(0.81)	0.00	0.00	7.46	(6.06)	28.33
HEPA	3.75	(0.37)	0.00	(0.12)	0.00	0.00	8.06	(8.11)	33.54
ELEV	3.51	(0.48)	0.00	(0.11)	0.00	0.00	5.77	(8.22)	22.21
AVRO	1.77	0.20	0.01	(0.30)	1.89	(2.24)	4.11	(3.17)	14.20

Inovio Pharmaceuticals Corporate Management

Asli Gevgilili	Chief Officer	Profile
Jeffrey Skolnik	Senior Development	Profile
Robert Juba	Senior Management	Profile
E MBA	Senior Assurance	Profile
MBA MA	Senior Development	Profile
Ben Matone	Director Relations	Profile
Laurent Humeau	Chief Scientific Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC